Inogen, Inc.
NASDAQ:INGNMedical - Devices
Healthcare
$5.42 +0.71%
+$0.05 today
- Market cap
- $140.93M
- Beta
- 1.60
- P/E (TTM)
- -7.0
- EPS (TTM)
- -$0.91
52W Low $5.34High $9.13
Volume 0.22M
Average 0.33M
Income Statement
Follow revenue through to earnings.
Revenue
$348.67M
FY 2025 · Annual
+3.9% YoYOperating Income
-$30.21M
FY 2025 · Annual
Net Income
-$22.75M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 358M | 377.24M | 315.66M | 335.71M | 348.67M |
| Cost of Revenue | 181.52M | 223.71M | 188.96M | 180.96M | 182.78M |
| Gross Profit | 176.48M | 153.53M | 126.7M | 154.74M | 165.89M |
| Gross Margin | 49.3% | 40.7% | 40.1% | 46.1% | 47.6% |
| Research & Development | 16.58M | 21.94M | 20.84M | 21.61M | 19.4M |
| Selling, General & Admin | 150.67M | 164.67M | 182.35M | 175.65M | 165.07M |
| Operating Expenses | 167.24M | 238.78M | 236.09M | 197.26M | 196.1M |
| Depreciation & Amortization | 21.63M | 23.51M | 18.15M | 21M | 20.66M |
| EBITDA | 30.29M | (9.57M) | (58.34M) | (15.47M) | (2.72M) |
| EBITDA Margin | 8.5% | -2.5% | -18.5% | -4.6% | -0.8% |
| Operating Income | 9.24M | (85.24M) | (109.39M) | (42.52M) | (30.21M) |
| Operating Margin | 2.6% | -22.6% | -34.7% | -12.7% | -8.7% |
| Interest Income | 129K | 2.84M | 6.57M | 5.19M | 2.15M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (581K) | 1.98M | 7.04M | 6.04M | 6.83M |
| Income Before Tax | 8.66M | (83.27M) | (102.34M) | (36.48M) | (23.38M) |
| Pre-Tax Margin | 2.4% | -22.1% | -32.4% | -10.9% | -6.7% |
| Income Tax Expense | 14.99M | 504K | 105K | (588K) | (632K) |
| Net Income | (6.33M) | (83.77M) | (102.45M) | (35.89M) | (22.75M) |
| Net Margin | -1.8% | -22.2% | -32.5% | -10.7% | -6.5% |
| EPS (Basic) | (0.28) | (3.67) | (4.42) | (1.52) | (0.85) |
| EPS (Diluted) | (0.28) | (3.67) | (4.42) | (1.52) | (0.85) |
| 22.49M | 22.85M | 23.18M | 23.65M | 27.18M | |
| 22.49M | 22.85M | 23.18M | 23.65M | 27.18M |
INGN Earnings Waterfall · TTM
NASDAQ:INGN · Revenue to Net Income
Key Ratios
EPS$-0.91
Gross Margin48.8%
Net Margin-7.2%
P/E Ratio-8.3
P/S Ratio2.2
Analysis
$351.5M of revenue converted into -$24.9M of net income for the selected period. Gross margin is 48.8% and net margin is -7.2%, showing how much revenue survives after costs and taxes. EPS is $-0.91, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 8-K | Current report | Sep 30, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 3, 2026 |
How much revenue does INGN generate?
Inogen, Inc. (INGN) reported $348.67M of revenue in fiscal 2025.
Is INGN profitable?
Inogen, Inc. (INGN) reported -$22.75M of net income, with a net margin of -6.5%.
Continue the stock analysis
Jump to another research area for this company.